EFFICIENCY OF EDARAVON IN THE ACUTE PERIOD OF ISCHEMIC STROKE DEPENDING ON AGE AND GENDER
Keywords:
ischemic stroke, the most acute and acute period, edaravoneAbstract
90 patients with acute ischemic stroke were examined and treated. Our study confirmed the effectiveness of the drug Edaravone, which was expressed in the positive dynamics of the indicators of the scales for assessing neurological deficit and motor activity by the 14th day (p<0.05) and amounted to 94.4%. The highest effectiveness (100%) was noted in the age groups of 35-49 and 50-59 years. The obtained data indicate the effectiveness of the drug Edaravone in the treatment of ischemic stroke in the most acute and acute periods, in different age groups, regardless of gender.
References
Маджидова Ё.Н., Иноятова С.О., Абдуқодиров Э.И. Зависимость цереброваскулярной патологии от выраженности эндотелиальной дисфункции // Неврология, 2024; 4(100):6-8.
Мирджураев Э.М., Адамбаев З.И., Жаббаров А.М., Кораева Л.К. Эффективность фитопрепарата NeuroAid II в остром периоде ишемического инсульта // «O‘zbekiston Harbiy Tibbiyoti», 2024; 5:252-256.
Chen C, Li M, Lin L, Chen S, Chen Y, Hong L. Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: A meta-analysis of randomized controlled trials. J Clin Pharm Ther 2021;46(4):907- 917. doi:10.1111/jcpt.13392. Collantes MEV, Miel Y, Zuñiga H, Uezono DR. Incidence and prevalence of stroke and its risk factors in the Philippines: A systematic review. Acta Medical Philippina 2022;54(14):26-
doi:10.47895/amp. vi0.1753.
Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021;20(10):795-820. doi:10.1016/S1474- 4422(21)00252-0.
Fidalgo M, Ricardo Pires J, Viseu I, et al. Edaravone for acute ischemic stroke – Systematic review with meta-analysis. Clin Neurol Neurosurg 2022;219. doi:10.1016/j.clineuro.2022.107299.
Kilichev I.A., Adambaev Z.I., Mateokubov M.O. Register of stroke in desert-steppe zones of Uzbekistan // American Journal of Medicine and Medical Sciences 2022, 12(4): 412-417 DOI: 10.5923/j.ajmms.20221204.09
Kilichev I.A., Matyokubov M.O., Adambaev Z.I., Khudayberganov N.Yu., Mirzaeva N.S. Register of stroke in the desert-steppe zones of Uzbekistan // International Scientific conference "Ecological and Biological Well-Being of Flora and Fauna" (Blagoveshchensk, Amur region, Russia, May 22 - 25, 2023), BIO Web of conferences 65, 04002 (2023) EBWFF 2023.- P.1-12.
Li X, Ma D, Sun G. Effects of edaravone on neurological function and tumor necrosis factor alpha and interleukin 8 levels in patients with cerebral infarction. Eur Neurol 2020;83(1):73-9. doi:10.1159/000505776.
Stephanie Patricia J. Badillo, Jose C. Navarro Safety of edaravone in acute ischemic stroke: A systematic review and meta-analysis // Neurology Asia 2023; 28(1):39–53
Yang HQ, Yin WJ, Liu K, Liu MC, Zuo XC. Renal safety evaluation of aspirin plus edaravone in patients with ischaemic stroke: a retrospective cohort study. BMJ Open 2022;12(4). doi:10.1136/ bmjopen-2021-055469.
